Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by joyjac – Philippines, 2006-05-10 07:44 (6239 d 09:35 ago) – Posting: # 122
Views: 7,509

Dear HS,

Just to clarify in case of (2): 90% CI will be applied to the parent drug and present the metabolite data descriptively - would this mean that ANOVA on the metabolite data is not necessary?

Thanks for sharing your expertise.

Complete thread:

UA Flag
 Admin contact
22,627 posts in 4,743 threads, 1,613 registered users;
15 visitors (0 registered, 15 guests [including 5 identified bots]).
Forum time: 17:20 CEST (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz